Frank P Vleggaar

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. ncbi Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
    Frank P Vleggaar
    Department of Gastroenterology, University Medical Center Utrecht, Utrecht, The Netherlands
    Eur J Gastroenterol Hepatol 20:688-92. 2008

Detail Information

Publications1

  1. ncbi Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
    Frank P Vleggaar
    Department of Gastroenterology, University Medical Center Utrecht, Utrecht, The Netherlands
    Eur J Gastroenterol Hepatol 20:688-92. 2008
    ..Inflammatory bowel disease concurs in 90% of primary sclerosing cholangitis (PSC) patients, suggesting that substances originating from the inflamed gut may damage the biliary tree...